Supplements Last reviewed: June 12, 2026

Does omega-3 supplementation reduce inflammation?

Strong Evidence
Confidence Score 79%

YES

Strong evidence shows omega-3 fatty acids (EPA and DHA) reduce inflammatory markers, particularly C-reactive protein and IL-6. Effects are most pronounced in people with elevated baseline inflammation.

The Verdict

Strong evidence shows omega-3 fatty acids (EPA and DHA) reduce inflammatory markers, particularly C-reactive protein and IL-6. Effects are most pronounced in people with elevated baseline inflammation.

What the Evidence Shows

Omega-3 fatty acids reduce inflammation through multiple mechanisms: they compete with arachidonic acid for enzymatic conversion, produce anti-inflammatory resolvins and protectins, and modulate NF-κB signaling. Large meta-analyses consistently demonstrate reductions in C-reactive protein (CRP), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-α). The anti-inflammatory effect is dose-dependent, with most benefits seen at 2-4g/day of combined EPA+DHA. Higher EPA ratios appear more effective for inflammation specifically. Effects are larger in individuals with existing inflammatory conditions (obesity, metabolic syndrome, autoimmune disease) compared to healthy individuals with normal inflammatory markers.

Evidence Quality

7

Meta-Analyses

40

RCTs

25

Observational

Important Caveats

  • ⚠️ Effects are dose-dependent — minimum ~2g/day EPA+DHA needed for meaningful anti-inflammatory effect
  • ⚠️ Benefits are most pronounced in those with elevated baseline inflammation
  • ⚠️ EPA appears more anti-inflammatory than DHA specifically
  • ⚠️ Takes 4-12 weeks of consistent use to see measurable changes in inflammatory markers
  • ⚠️ Source matters: fish oil and algae oil are effective; plant-based ALA converts poorly to EPA/DHA

Population Studied

Adults with and without inflammatory conditions; stronger effects in overweight/obese, metabolic syndrome, and autoimmune populations

Dosage

Most effective at 2-4g/day combined EPA+DHA; studies showing benefit typically used ≥1.5g EPA specifically

Duration

Measurable reductions in CRP seen after 4-8 weeks; optimal effects at 12+ weeks of consistent supplementation

Supporting Studies (3)

Omega-3 fatty acids and inflammatory processes: from molecules to man

Systematic Review

Calder PC. · Biochemical Society Transactions (2017)

EPA and DHA reduce production of inflammatory eicosanoids and cytokines through multiple mechanisms including NF-κB inhibition and specialized pro-resolving mediator production.

View paper (DOI) →

Effect of omega-3 fatty acids on C-reactive protein: a systematic review and meta-analysis

Meta-Analysis

Li K, Huang T, Zheng J, et al. · Atherosclerosis (2014)

Omega-3 supplementation significantly reduced CRP levels (pooled effect: -0.34 mg/L), with larger effects in those with higher baseline CRP and at doses >2g/day.

View paper (DOI) →

Marine omega-3 supplementation and systemic inflammation: a systematic review and meta-analysis

Meta-Analysis

Kavyani Z, Musazadeh V, Fathi S, et al. · Clinical Nutrition (2022)

Omega-3 supplementation significantly reduced CRP, IL-6, and TNF-α across 68 RCTs, with dose-response relationship favoring higher intakes.

View paper (DOI) →

Contradicting Studies (1)

Effect of omega-3 fatty acids on cardiovascular outcomes: a systematic review and meta-analysis

Meta-Analysis

Aung T, Halsey J, Kromhout D, et al. · JAMA Cardiology (2018)

Despite reducing inflammatory markers, omega-3 supplementation did not significantly reduce major cardiovascular events in 10 large RCTs involving 77,917 participants.

Why this disagrees:

While omega-3s clearly reduce measurable inflammation, this hasn't consistently translated into reduced cardiovascular events. This suggests inflammation reduction alone may not be sufficient for clinical benefit, or that the doses used in large prevention trials (typically 1g/day) were too low.

View paper (DOI) →
Share:
Was this helpful?

Related Claims